Co-Chairs, Bruce R. Korf, MD, PhD, and Nicole J. Ullrich, MD, PhD, MMSci, discuss NF1 in this CME/MOC activity titled “Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3gGrZUy. CME/MOC credit will be available until July 14, 2022.